Search the Newsreel

Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths

CAMBRIDGE, Mass., Aug. 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced that it will be included in MSCI Global Small Cap Indexes compiled by Morgan Stanley Capital International (MSCI). The change …

BofA Securities Adjusts Medical Properties Trust Price Target to $4.25 From $5

BofA Securities has revised its price target for Medical Properties Trust (MPT) to $4.25, down from $5.00. This adjustment comes shortly after MPT announced it would maintain its quarterly dividend at $0.09 per share and completed a $2.4 billion note issuance for debt refinancing. …

Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attached

Vivani Medical has filed an 8-K report, attaching a slide presentation as Exhibit 99.1. This presentation was distributed to the investment community and at conferences, providing key information about the company. The company notes that the presentation reflects information only as of the filing …

Form 8K PROFOUND MEDICAL CORP. For: 17 August By Investing.com

The article reports that Profound Medical Corp. filed a Form 8K on August 17. This filing is a standard requirement for public companies to announce major events that shareholders should know about. No specific details about the content of the 8K are provided in …

Themis Medicare updates Company Secretary and RTA contact emails

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of TransMedics Group, Inc. (NASDAQ: TMDX) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss potential legal rights and options, including corporate governance …

Medical Developments International Firms Ahead of FY26 Results — Is Penthrox Turnaround Finally Taking Hold?

Profound Medical (PROF) shifts CFO, ex-finance chief stays on as paid adviser

Profound Medical Corp. (PROF) has appointed Matthew Sobczyk as Interim Chief Financial Officer, effective August 14, 2026, following the resignation of Rashed Dewan. Dewan will receive a severance package and will provide transition and advisory services as a paid consultant until November 25, 2026. …

NeuroOne Medical (NMTC) Advances 6% to $1.94, Approaching Key Resistance - RSI Oversold Picks

AVNS Q1 2026 Earnings: EPS Beats Estimates by 54%, Revenue Data Not Disclosed - Earnings Sentiment Score

Raymond James raises Praxis Precision Medicines price target on pipeline outlook

Raymond James has increased its price target for Praxis Precision Medicines Inc. (NASDAQ:PRAX) shares from $765 to $945, maintaining a Strong Buy rating. This upgrade is driven by an increased probability of success for the company's EMERALD trial and higher peak sales forecasts for …

Star Sports Medicine Co: Revenue up 21.6% and adjusted profit up 24.3%, driven by strong global expansion

Medicamen Biotech Ltd Falls to 52-Week Low of Rs 214.9 as Sell-Off Deepens

RCEL Q2 2026 Earnings: Narrower Quarterly Loss Beats Estimates; Shares Slip 2% - Earnings Quality Analysis

Star Sports Medicine Boosts Revenue but Sees Interim Profit Decline on Higher Costs

Medicamen Biotech Ltd. Share Price Fall: Stock Analysis

Raily Aesthetic Medicine Sets Board Meeting to Review Interim Results and Dividend

ETFs Investing in Seach Medical Group Ltd. Stocks

Guanze Medical to Review 2026 Interim Results and Consider Dividend at August Board Meeting

SBC Medical (SBC) Q2 Revenue Beats Estimates; Valuation Remains Unclear Amid GF Score™ Challenges

522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC

Renaissance Technologies LLC acquired 522,900 shares of Treace Medical Concepts, Inc. ($TMCI) in the first quarter, valued at approximately $701,000, giving them a 0.81% stake. Other institutional investors also adjusted their holdings, with hedge funds and institutions collectively owning 84.08% of the company. Despite …

OncoSil Medical (ASX:OSL) Shares Fall 7.5% as FDA Window Elapses

Law firm investigates TransMedics officers for possible shareholder duty breaches

Halper Sadeh LLC is investigating whether officers and directors of TransMedics Group, Inc. (TMDX) breached their fiduciary duties to shareholders. Long-term shareholders are encouraged to seek free consultations for potential corporate governance reforms, financial incentives, or other relief. The firm emphasizes the urgency for …

TSX:MDNA Jumps 15%: What Is Driving Medicenna Therapeutics Stock Higher?

FY2028 EPS Estimates for MediciNova Lowered by HC Wainwright

HC Wainwright has lowered its FY2028 EPS estimate for MediciNova to $0.28 from $0.29, although this revised estimate is still above the current consensus loss estimate. The biopharmaceutical company recently reported a quarterly loss of $0.05 per share, beating analyst expectations, with revenues also …

FY2026 EPS Estimates for Journey Medical Lowered by Analyst

Fresenius Medical Care stock holds firm as market cap stays at $13.78 billion

Fresenius Medical Care (DE0005785802) stock is holding steady with a market capitalization of $13.78 billion and a share price of $25.66 as of August 2026. The stock's value is 1.26% above its year-earlier level, indicating a stable trend rather than dramatic fluctuations. The company's …

Actinogen Medical Seeks ASX Quotation for 3.2 Million New Shares

Orbusneich Medical Group Holdings Limited Appoints Kwai Ching Denise Lau as Co-Chief Executive Officer, Effective August 17, 2026

Daily Special: Dimerix, Astral Resources, Midas Minerals, ABx Group, OncoSil Medical

Pro Medicus (ASX:PME) Shares Dip as Contract Pipeline and FY26 Results Draw Focus

OncoSil Medical (ASX:OSL) Secures FDA Approval, Opening US Pathway for Targeted Cancer Device

What's Going On With Medicenna Therapeutics Corp Stock Sunday?

Baird Medical (BDMD) Slips 0.88% to $1.13, Holding Above Key Support at $1.07 - VWAP Bounce

Avita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%

Avita Medical (NASDAQ: RCEL) has increased its 2026 revenue guidance to $86 million–$89 million, up from $80 million–$85 million, after a strong second quarter where sales grew 18% year-over-year to $21.7 million. The wound-care company is also on track to achieve cash-flow breakeven in …

Avita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth Builds

Avita Medical (NASDAQ: RCEL) aims to achieve cash flow breakeven in Q4 2025, driven by strong revenue growth and disciplined operating expenses. The company has raised its 2025 revenue guidance to $86 million–$89 million and expects continued expansion for its wound care product portfolio, …